GENE, an esteemed journal published by Elsevier, serves as a vital resource for researchers and professionals in the fields of genetics and medicine. With an ISSN of 0378-1119 and an E-ISSN of 1879-0038, this scholarly journal has been at the forefront of genetic research since its inception in 1976 and is set to continue until 2025. Situated in the Netherlands, GENE is recognized for its significant contributions, reflected in its Q2 ranking in both Genetics and Miscellaneous Medicine categories for 2023. This positioning within the Scopus rankings demonstrates its impact and relevance in a competitive field, where it holds the rank of #129 out of 347 in Genetics, placing it within the 62nd percentile. Although it does not offer open access options, GENE provides invaluable insight into contemporary genetic research, thereby fostering academic discussions and advancements. Researchers, professionals, and students alike will find GENE an essential platform for disseminating knowledge and exploring innovative developments in genetics and associated sciences.

Environmental Epigenetics, published by Oxford University Press, is a leading open access journal dedicated to advancing the understanding of the epigenetic mechanisms that underpin environmental influences on health and disease. With an ISSN of 2058-5888 and established as an open access platform since 2015, this journal serves as a vital resource for researchers in the fields of genetics, environmental science, and health, offering insights from multidisciplinary perspectives. The journal has gained notable recognition in the academic community, reflected by its impressive Scopus rankings and its classification in the second quartile (Q2) for Genetics and other related disciplines as of 2023. It aims to foster innovative research that bridges laboratory findings and real-world environmental issues, making it an indispensable tool for professionals and students pursuing knowledge at the intersection of genetics, environmental science, and public health. With its commitment to disseminating valuable research findings freely, Environmental Epigenetics stands out as an essential publication for those aiming to understand the significant impacts of environmental factors on genetic expression.

DNA AND CELL BIOLOGY, published by Mary Ann Liebert, Inc, is a distinguished journal in the realms of cell biology, genetics, and molecular biology, holding a notable position in its Q3 and Q2 quartile rankings across multiple academic categories as of 2023. With an ISSN of 1044-5498 and an E-ISSN of 1557-7430, this journal has been a pivotal platform for the dissemination of cutting-edge research since its inception in 1990, extending its coverage through 2024. Situated in the United States, the journal offers high-quality peer-reviewed articles, exploring significant advancements in biological sciences while fostering interdisciplinary collaborations within the research community. Though it currently does not offer open access, subscribed institutions and individual readers benefit from its rich repository of knowledge. The journal's rigorous standards and impactful content make it an essential resource for researchers, professionals, and students alike, aiming to stay at the forefront of discoveries influencing DNA and cellular dynamics.

RNA is a premier journal in the field of molecular biology, published by COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT. With an impressive impact factor reflected by its Q1 status in the Molecular Biology category, this journal has established itself as an essential resource for researchers and professionals dedicated to understanding the role of RNA in biological processes. Spanning over two decades of impactful research from 1995 to 2024, RNA covers a broad spectrum of topics, including RNA biology, gene regulation, and therapeutic innovations. Researchers can access its extensive array of original research articles, reviews, and commentary, making it a vital conduit for new discoveries and methodologies in the field. With its high ranking within Scopus at Rank #115/410 and a 72nd percentile ranking in the domain of Biochemistry, Genetics, and Molecular Biology, RNA continues to advance the understanding of RNA and its critical contributions to life sciences.

Molecular & Cellular Oncology, published by Taylor & Francis Inc, is a vital academic journal dedicated to the exploration of cancer biology through the lens of molecular and cellular mechanisms. Since its inception in 2014, the journal has played a crucial role in disseminating innovative research findings that address the fundamental aspects of cancer research and molecular medicine. With its current ranking in Scopus placing it in the Q3 quartile for both Cancer Research and Molecular Medicine, the journal provides a platform for groundbreaking studies that push the boundaries of our understanding of oncogenesis and therapeutic interventions. Although the journal operates under a subscription model, its dedication to high-quality peer-reviewed research makes it an essential resource for researchers, professionals, and students aiming to contribute to or stay updated in the rapidly evolving field of oncology. As we approach the culmination of its converged years in 2024, Molecular & Cellular Oncology aims to continue fostering collaborations and insights that advance cancer research on a global scale.

Human Gene is an innovative open access journal published by ELSEVIER, dedicated to the ever-evolving field of genetics. Established in 2022, this journal serves as a vital resource for researchers, professionals, and students alike, aiming to facilitate the dissemination of groundbreaking research and advancements in both basic and clinical genetics. With an ISSN of 2773-0441, Human Gene focuses on providing a platform for high-quality studies that investigate genetic mechanisms, their implications in health and disease, and novel therapeutic strategies. The journal currently holds a Q4 ranking in both Genetics and Clinical Genetics categories, reflecting its emerging status within the scientific community, and strives to enhance its impact to better serve an engaged audience. With its base in Amsterdam, Netherlands, Human Gene is committed to making research accessible through its open access model, inviting contributions that advance our understanding of human genetics and foster collaboration across disciplines.

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, published by Wiley, stands at the forefront of research dedicated to the intricate relationship between genetics and neuropsychiatric disorders. With an impressive scope that bridges various disciplines, this journal serves as a premier platform for groundbreaking studies and innovative perspectives in the fields of Cellular and Molecular Neuroscience, Genetics, and Psychiatry and Mental Health. Featuring a robust impact factor and categorized in the Q1 and Q2 quartiles across multiple relevant categories, the journal has successfully positioned itself as a leading source of high-quality research, ranking 52nd in Cellular and Molecular Neuroscience, 37th in Clinical Genetics, and 157th in Psychiatry and Mental Health within Scopus. Since its inception in 1995, it has sustained a commitment to fostering scholarly excellence and advancing our understanding of the genetic underpinnings of mental health. The journal is poised to continue its mission until 2024 and offers open access options, facilitating wider dissemination of vital knowledge among researchers, healthcare professionals, and students alike.

Epigenetics & Chromatin, published by BMC, is a leading open-access journal that has been at the forefront of research in the fields of genetics and molecular biology since its inception in 2008. With an impressive Q1 category ranking in both Genetics and Molecular Biology as of 2023, this journal is pivotal for researchers and professionals aiming to explore the complexities of gene regulation and chromatin dynamics. The journal is renowned for its commitment to disseminating high-quality research, featuring diverse articles ranging from original research to comprehensive reviews. It enjoys a significant impact within the academic community, evidenced by its Scopus rankings that place it among the top 30% of journals in Genetics and the top 40% in Molecular Biology. With a dedicated open-access model, Epigenetics & Chromatin ensures that its comprehensive content is readily accessible to researchers globally, fostering collaboration and innovation across the scientific landscape. Located in the UK, the journal continues to attract a diverse audience of scholars and practitioners passionate about understanding the intricate layers of epigenetic regulation.

Non-Coding RNA is a prestigious open-access journal published by MDPI, based in Switzerland, dedicated to the significant and rapidly evolving field of non-coding RNA research. Established in 2015, this journal has quickly become an essential resource for researchers and professionals, showcasing innovative studies and breakthroughs related to the functions and mechanisms of non-coding RNAs in various biological processes. With an impressive Q1 ranking in Biochemistry and strong rankings in Genetics and Molecular Biology, Non-Coding RNA consistently reflects the highest standards of academic publishing. The journal provides comprehensive access options, granting researchers worldwide the ability to disseminate and access high-quality research without subscription barriers. As the landscape of genomics and molecular discoveries continues to expand, the journal aims to foster interdisciplinary exchanges and collaborations, making it a vital platform for advancing knowledge and innovation in this critical area of biological science.

CURRENT GENOMICS is a premier journal published by Bentham Science Publishers that focuses on the expansive field of genomics, including both clinical and molecular genetics. With the ISSN 1389-2029 and E-ISSN 1875-5488, this esteemed journal has been disseminating significant scientific insights since its inception in 2000 and continues to contribute to the field through 2024. Based in the United Arab Emirates, CURRENT GENOMICS boasts a Q3 ranking in both the genetics and clinical genetics categories for 2023, reflecting its growing impact in the scientific community. Although not an open-access journal, it provides valuable content that supports researchers and professionals in navigating the complexities of genetic research and its applications. By publishing original research articles, reviews, and case studies, CURRENT GENOMICS aims to foster a deeper understanding of genomic science and its implications for medicine, thus playing a critical role in the advancement of genetics and biomedical research.